| Fakhreddin Jamali | |
| Birth Date: | 1945 5, mf=yes |
| Birth Place: | Arak, Iran |
| Fields: | pharmaceutical sciences |
| Workplaces: | University of Alberta |
| Education: | University of British Columbia (PhD) University of Tehran (Pharm.D.) |
| Known For: | founding the Canadian Society for Pharmaceutical Sciences |
| Awards: | Alberta Centennial Medal, AAPS fellowship, CSPS fellowship, Killam Professorship |
| Spouse: | Elaheh Keshavarz-Jamali (b. 1945- d. 2020) [1] |
| Partners: | )--> |
| Children: | 1 |
Fakhreddin Jamali (born May 31, 1945) is an Iranian-Canadian professor emeritus of pharmacy and pharmaceutical sciences at the University of Alberta. He is the founding president of the Canadian Society for Pharmaceutical Sciences,[2] and the editor-in-chief of Journal of Pharmacy and Pharmaceutical Sciences.[3]
Fakhreddin was born May 31, 1945, in Arak, Iran to Jamaleddin Jamali and Batoul Rouhani-Jamali.[4] [5]
Jamali's focus has been on drugs action (pharmacodynamics) and disposition (pharmacokinetics) particularly in field of analgesics and antiinfammatory therapy. His earlier work on the stereoselective and stereospecific therapeutic and toxicity of drugs received high peer recognition.[6] He also reported that pain and/or its trauma delays absorption of drugs which may render them ineffective.[7] This is particularly important when a quick action is desired such as pain relief. His group found that inflammatory conditions such as arthritis diminish response to some cardiovascular drugs despite already known increased circulatory concentrations.[8] His group also has reported the mechanism behind the adverse cardiovascular effects of both anti-inflammatory drugs and inflammatory conditions.[9] [10] Jamali has received many national and international awards for his contribution to science and public wellbeing.[11]